The 3D multiomic determinants of prostate cancer lethality
Active Project Grant Awarded Last action
- Award ID
- HT9425261E158
- Recipient
-
University Of California, LOS Angeles UEI RN64EPNH8JC6
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,698,858
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 14% complete
- Place of performance
- Los Angeles, CA 90024, USA
Award details come from USAspending.gov.
About this award
The Defense Health Agency awarded the University of California, Los Angeles $1,698,858 on June 1, 2026, for a Project Grant titled "The 3D Multiomic Determinants of Prostate Cancer Lethality" under the Military Medical Research and Development program (CFDA 12.420). The award funds research investigating subclonal methylome-genome heterogeneity in prostate tumors using single-cell 3D multi-omics and development of a single-cell 3D multi-omic prognostic marker for localized prostate cancer lethality. Performance runs through May 31, 2029, at UCLA's Los Angeles campus. The Sanford Burnham Prebys Medical Discovery Institute receives pass-through funding as a sub-grantee, contributing to delineation of subclonal methylome-genome heterogeneity across a large prostate tumor cohort and development of the prognostic marker for cancer lethality.
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Sanford Burnham Prebys Medical Discovery Institute | $169,207 |
Quick answers
Who received award HT9425261E158?
HT9425261E158 was awarded to University Of California, LOS Angeles by Defense Health Agency (Department of Defense) on June 1, 2026.
How much is award HT9425261E158 worth?
$1,698,858 has been obligated on HT9425261E158.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award